Zhesheng Chen

Oncology · 2010–2022

A researcher in the Science corpus: 6 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Zhesheng Chen trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Goldman (in Hematology)
  2. Michael M. Gottesman (in Oncology)

Papers from Zhesheng Chen's perspective

Ordered by how strongly the researchers Zhesheng Chen trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy. (Blood)
  2. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. (Blood)
  3. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. (New England Journal of Medicine)
  4. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification (Science)
  5. The molecular biology of chronic myeloid leukemia. (Blood)
  6. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. (New England Journal of Medicine)
  7. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. (New England Journal of Medicine)
  8. Multidrug resistance in cancer: role of ATP–dependent transporters (Nature Reviews. Cancer)
  9. The E. coli BtuCD Structure: A Framework for ABC Transporter Architecture and Mechanism (Science)
  10. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. (New England Journal of Medicine)

Their papers